Management of Refractory Eosinophilic Fasciitis Using Biologic Therapies, Janus Kinase Inhibitors, and Intravenous Immunoglobulin: A Systematic Review.
Mitwalli Mohammed M, Waked Jihad Abou Ali JAA, Sood Siddhartha S, Abduelmula Abrahim A et al.
LFB · 多克隆抗体 · 多克隆抗体
polyvalent human immunoglobulin (liquid) 是一种多克隆抗体,由LFB研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。
| 商品名 | Clairyg |
| 公司 | LFB |
| 药物类别 | 多克隆抗体, 抗体 |
| 给药途径 | Injectable (Others), Intravenous (IV) |
| 状态 | Approved |
polyvalent human immunoglobulin (liquid) 针对 7 个适应症,涉及 5 个治疗领域。
| 治疗领域 | 疾病/病症 | 分期 |
|---|---|---|
| Nervous system disorders | Guillain-Barre syndrome | ✓ Approved |
| Skin and subcutaneous tissue disorders | Purpura | ✓ Approved |
| Congenital, familial and genetic disorders | Wiskott-Aldrich syndrome | ✓ Approved |
| Immune system disorders | Selective IgG subclass deficiency | ✓ Approved |
| Congenital, familial and genetic disorders | Bruton's agammaglobulinaemia | ✓ Approved |
注册免费账户还可查看另外 2 个适应症
免费注册查看全部适应症 →Mitwalli Mohammed M, Waked Jihad Abou Ali JAA, Sood Siddhartha S, Abduelmula Abrahim A et al.
Parkhideh Seyedeh Zahra SZ, Forouzesh Mehdi M, Akhgari Maryam M, Akbarzadeh Kamran K et al.
Entomotoxicology provides an alternative matrix for detecting drugs in decomposed human remains when conventional specimens are unavailable. This study aimed to develop and validate a quantitative method for detecting methamphetamine (MA) in different developmental stages of the blowfly Lucilia sericata. Immature stages of L. sericata (larvae, pupae, empty puparia) were reared on chicken liver spiked with MA at concentrations of 45, 90 and 180 ng/mg. Samples underwent liquid-liquid extraction, derivatization via acetylation, and analysis using gas chromatography-mass spectrometry (GC-MS). The method was validated according to international guidelines, evaluating limit of detection (LOD), limit of quantification (LOQ), linearity, precision, accuracy and repeatability. The method showed strong linearity across the studied concentration range (R2= 0.9817-0.9934). The limit of detection and LOQ were 15 ng/mg and 45 ng/mg, respectively, with a relative standard deviation (RSD)≤ 20% at the LOQ level. Intra- and inter-day precision showed RSD values< 10%, and accuracy ranged from 98.55% to 100.73%. Methamphetamine was detected in all immature stages and empty puparia. The highest observed concentrations were detected in third-instar larvae and pupae, whereas no drug residues were detected in adult flies. Methamphetamine retention in empty puparia supports their potential forensic relevance for retrospective drug detection. This validated method demonstrated acceptable sensitivity, precision, accuracy and repeatability for quantitative entomotoxicological analysis. The detection of methamphetamine across insect developmental stages suggests the suitability of this approach as a supplementary tool for forensic investigations involving decomposed remains.
Goktas Cansu C, Aydogan Nihal N
Liquid marbles have attracted a significant amount of attention because of their dynamic programmable nature. In the present study, we propose the conceptualization and implementation of a novel dual-stimulus-responsive liquid marble (LM) platform actuated by near-infrared (NIR) light and magnetic fields and capable of exhibiting controllable locomotion behavior in response to changes in interfacial tension. The integration of external stimuli within a single liquid marble system has been achieved by means of two different micro- and nanoscale functional coating particles and a magnetically responsive core liquid. The liquid marble shell formed through the utilization of hydrophobic polypyrrole particles (SPP), which exhibit high photothermal energy in conjunction with hydrophobic magnetic nanoparticles (F-MNP), which provide magnetic responsiveness. In addition, ferrofluid (FF) has the capacity to respond to an applied magnetic field and is utilized as a core material. The resulting liquid marbles exhibited controllable locomotion under NIR irradiation, magnetic actuation, and combined stimuli through the utilization of near-infrared light-induced Marangoni flows and magnetic field-driven forces. In the presence of external stimuli, these systems generate asymmetric interfacial stress gradients at the liquid-air interface, resulting in the observed controllable locomotion. A systematic investigation was conducted to explore the impact of the particle type, magnetic field, and NIR exposure on the movement behavior of liquid marbles on water and polyacrylamide (PAM) hydrogel surfaces. This work demonstrates the potential of dual-stimulus-responsive liquid marbles as a programmable smart actuation system.
Murugesan Ram Prabahar RP, Sivanandam Sathiyan S, Jayam Jayanivash J, Kurian Anila A AA
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) represents a distinct glomerular pathology, classified under monoclonal gammopathy of renal significance (MGRS). In renal transplant, PGNMID usually develops as a recurrent disease, but can rarely arise de novo. Recurrence is relatively common, typically appearing within five to six months post-transplant, and is linked to poor graft outcomes. De novo PGNMID is exceedingly rare, with few reported in the literature. It generally presents in the late post-transplant period, with a more indolent clinical course and a variable response to immunotherapy. This case report is of a 50-year-old patient who had diabetic nephropathy as his native kidney disease. This report documents a unique instance of de novo PGNMID, occurring three years post-transplantation with persistent allograft dysfunction. The transplant kidney biopsy showed mesangial hypercellularity with immunoglobulin (Ig)G and kappa light chain deposition by immunofluorescence; however, electron microscopy was non-contributory due to the absence of viable glomeruli. Despite extensive evaluation, we could not identify any clone contributing to the MGRS in the bone marrow, nor could we identify any other evidence of lymphoproliferative disease on positron emission tomography-computed tomography (PET-CT). We managed the patient with empirical clone-directed therapy against a likely B-cell clone using Rituximab. During rituximab therapy, the patient developed E. coli urosepsis, which was managed successfully. At the last follow-up, graft function remained stable without progression, although the duration of follow-up is limited.
Shao Shimin S, Liu Yujian Y, Xu Yifeng Y, Liu Zhiyang Z et al.
Liquid crystal elastomers (LCEs) are promising soft actuators, but their practical use is constrained by the incompatibility between fire safety and reversible actuation. Extrinsic flame-retardant strategies can disrupt the liquid-crystal organization and network integrity required for deformation, whereas existing phosphorus-containing liquid crystal polymers (LCPs) are mainly rigid, aromatic thermoplastics designed for structural heat resistance rather than actuation. Here, we report a radical-mediated P─H/ene step-growth polymerization strategy for intrinsically flame-retardant organophosphorus LCPs and LCEs using hypophosphorous acid and diene-terminated mesogenic monomers. This main-chain P─C bond-forming strategy avoids rigid aromatic phosphorus units and affords phosphorus-containing liquid-crystalline systems with reduced phase-transition temperatures together with a high phosphorus content of up to 6.8 wt.%. The resulting LCEs retain thermotropic liquid-crystalline behavior, exhibit reversible thermoactuation, and show pronounced flame retardancy characterized by reduced heat release, self-extinguishing behavior, and phosphorus-promoted char formation. Notably, these organophosphorus LCEs also enable flame-triggered actuation within only 0.4 s while preserving structural integrity and reversible function after flame exposure. This work establishes a practical molecular design route toward intrinsically flame-retardant LCE actuators for thermally harsh environments.
Abdel-Razeq Hikmat H, Sharaf Baha B
Hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC) is the most prevalent subtype of advanced breast cancer and is predominantly driven by estrogen receptor (ER) signaling. Endocrine therapy (ET) has become the backbone of first-line treatment; however, both intrinsic and acquired resistance limit long-term disease control. The introduction of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors has fundamentally reshaped the therapeutic landscape even in subsets of patients with aggressive or symptomatic visceral metastatic disease. Advances in molecular profiling have also enabled more precise, adaptive therapy. Circulating tumor DNA (ctDNA)-based liquid biopsy now allows real-time detection of emerging resistance mutations, particularly in ESR1. Additionally, patients with PIK3CA-mutated tumors who had progressed on or within 12 months of completing adjuvant ET and had no prior systemic therapy for metastatic disease had better treatment outcomes when treated with the PI3K inhibitor inavolisib in combination with palbociclib and fulvestrant. Together, these developments mark a shift from fixed treatment sequencing toward a more dynamic, biomarker-driven approach in first-line HR+/HER2- MBC. Integration of CDK4/6 inhibitors with next-generation endocrine agents and liquid biopsy-guided therapy offers the potential to delay resistance, improve survival outcomes, and individualize treatment.
注册免费账户还可查看另外 9996 篇文献
免费注册查看全部文献 →